NEW YORK, June 11 (Reuters) - Biopharmaceutical company
Dynavax Technologies ( DVAX ) on Wednesday defeated investment
firm Deep Track Capital's effort to unseat directors when
investors re-elected all four candidates, the company said in a
statement.